Cipla Ltd. — Capital/Financing Update 2025

Feb 3, 2025

==> picture [84 x 30] intentionally omitted <==

3[rd] February 2025

(1) BSE Limited (2) National Stock Exchange of India Limited Listing Department, Listing Department Phiroze Jeejeebhoy Towers, Exchange Plaza, 5[th] floor, Dalal Street, Plot no. C/1, G Block, Mumbai 400 001 Bandra Kurla Complex, Bandra (East), Mumbai - 400 051 Scrip Code: 500087 Scrip Code: CIPLA

(3) SOCIETE DE LA BOURSE DE LUXEMBOURG Societe Anonyme 35A Boulevard Joseph II, L-1840 Luxembourg

Sub: Investment in Cipla Medpro South Africa Proprietary Limited, wholly owned subsidiary

Dear Sir/Madam,

In compliance with the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), we hereby notify that the Company will invest approx. ZAR 900 million in equity share capital of Cipla Medpro South Africa Proprietary Limited, a wholly-owned subsidiary of the Company in South Africa (“CMSA”).

Details required to be disclosed under the Listing Regulations read with Circular no. SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11[th] November 2024 on the captioned subject are enclosed to this letter.

We request you to kindly take the above disclosure on record.

Thanking you, Yours faithfully,

For Cipla Limited RAJENDR Digitally signed by RAJENDRA A KUMAR KUMAR CHOPRA Date: 2025.02.03 CHOPRA 15:29:16 +05'30' Rajendra Chopra Company Secretary

Prepared by: Akshaya Kolvankar

Cipla Ltd. Regd. Office - Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400 013, India P +91 22 41916000 F +91 22 41916120 W www.cipla.com E-mail contactus@cipla.com Corporate Identity Numbe r L24239MH1935PLC002380

==> picture [84 x 30] intentionally omitted <==

Annexure – I

Details as per the SEBI Circular no. SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11[th] November 2024

Sr.No.	Particulars	Details
a)	Name of the target entity, details in briefsuch as size, turnover, etc.	Cipla Medpro South Africa Proprietary Limited(“CMSA”)CMSA, is a wholly owned subsidiary of Cipla Limited,and is the holding company for the group operations inSouth Africa. The group is involved in themanufacturing,marketing,andsupplyofpharmaceutical products.Turnover as on 31stMarch 2024:ZAR 688.28 million
b)	Whether the acquisition would fallwithin related party transaction(s) andwhetherthepromoter/promotergroup/ group companies have anyinterest in the entity being acquired? Ifyes, nature of interest and detailsthereof and whether the same is done at“arm’s length”	The transaction is a related party transaction and willbe at arm’s length.Noneofthepromoter/promotergroup/groupcompanies have any interest in the entity.
c)	Industry to which the entity beingacquired belongs	Pharmaceutical
d)	Objects and impact of acquisition(including but not limited to, disclosureof reasons for acquisition of targetentity, if its business is outside the mainline of business of the listed entity)	The investment will be utilised to reduce inter-groupdebt and improve the capital structure of CMSA and itssubsidiaries.
e)	Brief details of any governmental orregulatory approvals required for theacquisition	Not Applicable.
f)	Indicative time-period for completion ofthe acquisition	The investment is expected to be completed on orbefore 28thFebruary 2025 or such other date mutuallyagreed between the parties.
g)	Consideration-whethercashconsideration or share swap or any otherform and details of the same	Cash consideration.

Cipla Ltd.

Regd. Office - Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400 013, India

P +91 22 41916000 F +91 22 41916120 W www.cipla.com E-mail contactus@cipla.com Corporate Identity Numbe r L24239MH1935PLC002380

==> picture [84 x 30] intentionally omitted <==

h)	Cost of acquisition and/or the price atwhich the shares are acquired		Cost of acquisition: ZAR 899,999,992Number of equity shares: 40,742,417
i)	Percentage of shareholding / controlacquired and / or number of sharesacquired
j)	Brief background about the entityacquired in terms of products/line ofbusinessacquired,dateofincorporation, history of last 3 years’turnover, country in which the acquiredentity has presence and any othersignificant information (in brief)		Brief background: Refer (a) above.Date of Incorporation: 15thJuly 2013History of last 3 years turnover:FYTurnoverFY 2023-24ZAR 688.28 millionFY 2022-23ZAR 1.12 billionFY 2021-22ZAR 1.71 billionCountry in which CMSA has its presence: South Africa

Cipla Ltd.

Regd. Office - Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400 013, India P +91 22 41916000 F +91 22 41916120 W www.cipla.com E-mail contactus@cipla.com Corporate Identity Numbe r L24239MH1935PLC002380